Successful initiation of an anal cancer screening and treatment program at a New York City HIV clinic

AIDS

Volumn 24, Issue 7, 2010, Pages 1085-1086

  Tider, Diane S ^a   Caprio, Gabriela Rodriguez ^a   Gaisa, Michael ^a   Klein, Robert S ^a   Goldstone, Stephen E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANUS CANCER; CANCER SCREENING; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE HOMOSEXUAL; MORBIDITY; MORTALITY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; ANUS NEOPLASMS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; NEW YORK CITY; PATIENT SELECTION;

EID: 77950939970     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328336e978     Document Type: Letter

References (21)

1. Shalev N, Olender SA, Chiasson MA. Targeted anal cancer screening in HIV-infected patients: prevalence of screening indicators. AIDS 2009; 23:1613-1615.
2. New York State Department of Health AIDS Institute. Neoplastic complications of HIV infection, anal dysplasia and cancer. www.hivguidelines. org. [Accessed October 2009]
3. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillo-mavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-527.
4. Nielson C, Harris R, Flores R, Abrahamsen M, Papenfuss R, Dunne EF, et al. Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomarkers Prev 2009; 18:1077-1083.
5. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.J Pathol 1999; 189:12-19.
6. Chaturvedi A, Madeleine M, Biggar R, Engels E. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101:1120-1130.
7. Chin-Hong PV, Palefsky JM. Human papillomavirus anogenital disease in HIV-infected individuals. Dermatol Ther 2005; 18:67-76.
8. Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337:1350-1358.
9. Hoots B, Palefsky J, Pimenta J, Smith J. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009; 124:2375-2383.
10. Johnson L, Madeleine M, Newcomer L, Schwartz S, Daling J. Anal cancer incidence and survival: the surveillance, epidemiology and end results experience, 1973-2000. Cancer 2994; 101:281-288.
11. Longacre TA, Kong CS, Welton ML. Diagnostic problems in anal pathology. Adv Anat Pathol 2008; 15:263-278.
12. Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr 1998; 23:15-20.
13. Panther LA, Schlecht HP, Dezube BJ. Spectrum of human papillomavirus-related dysplasia and carcinoma of the anus in HIV-infected patients. AIDS Read 2005; 15:79-82; 85-86, 88, 91.
14. Park I, Ogilvie JJ, Anderson K, Li ZZ, Darrah L, Madoff R, Downs L Jr. Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia. Gynecol Oncol 2009; 114:399-403.
15. Pierangeli A, Scagnolari C, Marta Degener A, Bucci M, Ciardi A, Riva E, et al. Type-specific human papillomavirus-DNA load in anal infection in HIV-positive men. AIDS 2008; 22:1929-1935.
16. Phillips AA, Justman JE. Screening HIV-infected patients for non-AIDS-defining malignancies. Curr HIV/AIDS Rep 2009; 6:83-92.
17. Horner M,RiesL, KrapchoM,Neyman N, AminouR, Howlader N, et al. SEER Cancer Statistics Review, 1975-2006; 2009.
18. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000; 342:792-800.
19. Cranston RD, Hirschowitz SL, Cortina G, Moe AA. A retrospective clinical study of the treatment of high-grade anal dysplasia by infrared coagulation in a population of HIV-positive men who have sex with men. Int J STD AIDS 2008; 19:118-120.
20. Stier EA, Goldstone SE, Berry JM, Panther LA, Jay N, Krown SE, et al. Infrared coagulator treatment of high-grade anal dyspla-sia in HIV-infected individuals: an AIDS malignancy consortium pilot study. J Acquir Immune Defic Syndr 2008; 47:56-61.
21. Goldstone SE, Kawalek AZ, Huyett JW. Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions. Dis Colon Rectum 2005; 48:1042-1054